A stent is a small and tiny wire web like tube that a special medical practitioner implants in the body of the patient in order to restore blood flow and support the vessel wall. Stents help to keep the coronary arteries open in order to decrease the rate of a heart attack. A stent reinstates the blood flow and flow of other fluids, based on where the stent is placed. One of the significant causes behind growing cardiovascular conditions is getting habitual to unhealthy lifestyle. Evolving way of life, for example, smoking, physical inactivity, and irregular eating habits hamper the health of the heart. These conditions are prompting probability of hypertension, stoutness, and blockages in supply routes. Thus, aging of population is another element that is driving the development of these items at a critical rate. The use of latest trends in medical field, for example, scaffolds, Bioresorbable stents, bifurcation stent, and biodegradable polymer with an appropriation of more up to date systems and negligibly intrusive strategies are inclining in this industry. These items are optional for bypass surgery. What’s more, when utilized as a part of insignificantly obtrusive methods, they offer certain points of interest over traditional surgeries, for example, less recovery time, shorter scars, less physical injury and less danger of infection and less bleeding.
How Big is The Global Stents Market?
The Global Stents Market is expected to be around US$ 27.40 Billion by 2028 at a CAGR of 9.5% in the given forecast period.
The major driving factors of Global Stents Market are as follows:
The restraining factors of Global Stents Market are as follows:
The Global Stents Market is segmented on the lines of its material, type and regional. Based on material segmentation it covers metallic biomaterials, polymers biomaterials, natural biomaterials. Based on type segmentation it covers coronary stents, peripheral stents, stent-related implants, The Global Stents Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Stents Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Stents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Stents Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., C. R. Bard, Inc, Elixir Medical Corp., Medtronic plc, Microport Scientific Corp., Stentys S.A., Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Stents Market has been segmented as below:
By Material Analysis:
By Type Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Stents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Stents Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Life Science Instrumentations market
Chapter 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes
3.4 Market share analysis, 2015
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.5.1.2 Technological advancements in the field of stents
3.5.1.3 Improvement of healthcare infrastructure in developing countries
3.5.1.4 Improved insurance and reimbursement
3.5.2 Restraints
3.5.2.1 High cost of treatment associated with stent implants
3.5.2.2 Stringent approval process for stents
3.5.3 Opportunities
3.5.3.1 Huge market opportunities in the developing countries
Chapter: 4 WORLD STENTS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.2 Coronary stents
4.2.1 Market size and forecast
4.2.2 Drug-eluting stents (DES)
4.2.2.1 Market size and forecast
4.2.3 Bare-metal coronary stents
4.2.3.1 Market size and forecast
4.2.4 Bioabsorbable stents
4.2.4.1 Market size and forecast
4.3 Peripheral stents
4.3.1 Market size and forecast
4.3.2 Iliac stents
4.3.2.1 Market size and forecast
4.3.3 Femoral-popliteal stents
4.3.3.1 Market size and forecast
4.3.4 Renal & related stents
4.3.4.1 Market size and forecast
4.3.5 Carotid stents
4.3.5.1 Market size and forecast
4.4 Stent-related implants
4.4.1 Market size and forecast
4.4.2 Synthetic grafts
4.4.2.1 Market size and forecast
4.4.3 Vena cava filters
4.4.3.1 Market size and forecast
Chapter: 5 WORLD STENTS MARKET, BY BIOMATERIAL
5.1 Overview
5.1.1 Market size and forecast
5.2 Metallic biomaterials
5.2.1 Market size and forecast
5.3 Polymeric biomaterials
5.3.1 Market size and forecast
5.4 Natural biomaterials
5.4.1 Market size and forecast
Chapter: 6 WORLD STENTS MARKET, BY GEOGRAPHY, 2022 2027
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size and forecast
6.2.5 Canada market size and forecast
6.2.6 Mexico market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size and forecast
6.3.5 France market size and forecast
6.3.6 U.K. market size and forecast
6.3.7 Italy market size and forecast
6.3.8 Spain market size and forecast
6.3.9 Rest of Europe market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 India market size and forecast
6.4.5 China market size and forecast
6.4.6 Japan market size and forecast
6.4.7 South Korea market size and forecast
6.4.8 Malaysia market size and forecast
6.4.9 Rest of Asia-Pacific market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size and forecast
6.5.5 South Africa market size and forecast
6.5.6 Egypt market size and forecast
6.5.7 Rest of LAMEA market size and forecast
Chapter: 7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.1.5 SWOT analysis
7.2 B. Braun Melsungen AG
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.2.5 SWOT analysis
7.3 Biotronik SE & Co. KG
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Key strategic moves & developments
7.3.4 SWOT analysis
7.4 Boston Scientific Corporation
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.4.5 SWOT analysis
7.5 C. R. Bard, Inc.
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.5.5 SWOT analysis
7.6 Elixir Medical Corporation
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Key strategic moves & developments
7.6.4 SWOT analysis
7.7 Medtronic plc
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.7.5 SWOT analysis
7.8 Microport Scientific Corporation
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.8.5 SWOT analysis
7.9 Stentys S.A.
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.9.5 SWOT analysis
7.10 Terumo Corporation
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments
7.10.5 SWOT analysis
The Global Stents Market has been segmented as below:
By Material Analysis:
By Type Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
